Alexander Nolte is Chief Accounting Officer at Syndax Pharmaceuticals Inc (SNDX). They have made 1 open-market trade across 1 company since 2022, most recently 2022-02-01.
CIK 0001891979
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SNDX | 968 | $10K |
Shares reported on the most recent Form 4, priced at the 2022-02-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SNDX | SELL | 2022-02-01 | 2022-02-03 | $16.65 | $16K | +10.4% | +9.7% | +16.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.